We are live on
!
Find out more
AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$960M
1-Year Est. Return
207.76%
This Fund
S&P 500
This Quarter
Est. Return
+5.71%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$752M
AUM Growth
+$110M
(+17%)
Cap. Flow
+$81.1M
Cap. Flow
% of AUM
10.79%
Top 10 Holdings %
Top 10 Hldgs %
40.28%
Holding
184
New
49
Increased
34
Reduced
33
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$17.2M |
| 2 |
Oracle
ORCL
|
+$13.2M |
| 3 |
Zimmer Biomet
ZBH
|
+$12.5M |
| 4 |
NGD
New Gold Inc
NGD
|
+$10.2M |
| 5 |
Incyte
INCY
|
+$9.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$17.2M |
| 2 |
SSNI
Silver Spring Networks, Inc.
SSNI
|
+$12.8M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$8.48M |
| 4 |
BRG
Bluerock Residential Growth REIT, Inc.
BRG
|
+$8.05M |
| 5 |
MarketAxess Holdings
MKTX
|
+$7.04M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.31% |
| 2 | Technology | 13.37% |
| 3 | Materials | 7.6% |
| 4 | Utilities | 6.6% |
| 5 | Industrials | 5.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Abeona Therapeutics
ABEO
$355M
| $853K | 0.11% |
2,000
-400
| -17% | -$107K |
|
77
Sociedad Química y Minera de Chile
SQM
$19.3B
| $835K | 0.11% |
15,000
-50,000
| -77% | -$2.25M |
|
|
SUM
78
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $801K | 0.11% |
+25,781
| New | +$732K |
|
79
Applied Materials
AMAT
$347B
| $781K | 0.1% |
+15,000
| New | +$678K |
|
|
WAAS
80
DELISTED
AquaVenture Holdings Limited
WAAS
| $743K | 0.1% |
55,000
+21,842
| +66% | +$333K |
|
81
Lam Research
LRCX
$316B
| $740K | 0.1% |
+40,000
| New | +$649K |
|
82
NVIDIA
NVDA
$4.6T
| $715K | 0.1% |
+160,000
| New | +$665K |
|
|
PPLI
83
People Inc
PPLI
$3.12B
| $705K | 0.09% |
+33,572
| New | +$652K |
|
|
BOLD
84
DELISTED
Audentes Therapeutics, Inc
BOLD
| $702K | 0.09% |
25,072
+5,000
| +25% | +$109K |
|
85
Andersons Inc
ANDE
$2.39B
| $685K | 0.09% |
+20,000
| New | +$662K |
|
86
Meta Platforms (Facebook)
META
$1.49T
| $683K | 0.09% |
+4,000
| New | +$668K |
|
87
Atlassian
TEAM
$26.5B
| $668K | 0.09% |
+19,000
| New | +$675K |
|
88
Cigna
CI
$78.4B
| $654K | 0.09% |
3,500
+1,000
| +40% | +$178K |
|
89
BioMarin Pharmaceuticals
BMRN
$11.9B
| $651K | 0.09% |
7,000
| – | – |
|
90
Darling Ingredients
DAR
$9.32B
| $613K | 0.08% |
+35,000
| New | +$592K |
|
91
Intuit
INTU
$91.1B
| $569K | 0.08% |
+4,000
| New | +$552K |
|
|
CBAY
92
DELISTED
Cymabay Therapeutics
CBAY
| $566K | 0.08% |
70,210
+20,000
| +40% | +$135K |
|
93
IES Holdings
IESC
$9.89B
| $519K | 0.07% |
+30,000
| New | +$498K |
|
94
Aclaris Therapeutics
ACRS
$715M
| $516K | 0.07% |
20,000
+5,000
| +33% | +$134K |
|
95
Take-Two Interactive
TTWO
$46.1B
| $511K | 0.07% |
5,000
-10,000
| -67% | -$895K |
|
|
TWTR
96
DELISTED
Twitter, Inc.
TWTR
| $506K | 0.07% |
30,000
+10,000
| +50% | +$175K |
|
97
Flex
FLEX
$37.7B
| $464K | 0.06% |
+37,156
| New | +$458K |
|
98
CALL
First Solar
FSLR
$21.4B
| $459K | 0.06% |
10,000
-40,000
| -80% | -$1.85M |
|
99
AbbVie
ABBV
$465B
| $444K | 0.06% |
5,000
-2,500
| -33% | -$190K |
|
100
8x8 Inc
EGHT
$279M
| $405K | 0.05% |
+30,000
| New | +$409K |
|
Similar funds
NA
MK
QIM
JVBC
TFP
UWPG
LOAMU
PHS
Ardsley Advisory Partners's Q3 2017 Portfolio in Review
As of Q3 2017, Ardsley Advisory Partners held 184 positions worth $752M, up 17% from $642M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Ardsley Advisory Partners deployed $81.1M of net new capital in Q3 2017, opening 49 new positions and adding to 34 existing holdings. Its largest new stake was Centene: 400,000 shares worth $19.4M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 12% a quarter earlier, followed by Technology and Materials.
On the sell side, the largest reduction was Celgene Corp, an estimated $17.2M trimmed.
- Ardsley Advisory Partners's largest Q3 2017 buy was Centene: 400,000 shares worth $19.4M.
- Ardsley Advisory Partners added most to Zimmer Biomet in Q3 2017, an estimated $12.5M increase.
- Ardsley Advisory Partners's biggest Q3 2017 reduction was Celgene Corp, cutting an estimated $17.2M.
- Ardsley Advisory Partners fully exited Bluerock Residential Growth REIT, Inc. in Q3 2017, selling an estimated $8.05M.
- Ardsley Advisory Partners's ten largest holdings make up 40% of its $752M portfolio in Q3 2017.
- Ardsley Advisory Partners opened 49 new positions and closed 54 in Q3 2017.
- Ardsley Advisory Partners's portfolio value rose 17% quarter-over-quarter to $752M.
Based on Ardsley Advisory Partners's 13F filing for Q3 2017, filed 14 Nov 2017.